Product Information
INDOMETHACIN ER 75 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.2099 per EA under NDC 31722056560. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722056560
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
INDOMETHACINApproval Type
Generic (ANDA)
FDA Application
ANDA201807FDA Approved
9/28/2012
TE Code
AB
On Market Since
7/24/2015
Pharmacological Classes
Price Statistics
The NADAC for INDOMETHACIN ER 75 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2099 per EA |
|---|---|
| All-time high | $1.4920 (Feb 12, 2014) |
| All-time low | $0.1511 (Nov 20, 2024) |
| 52-week high | $0.2230 |
| 52-week low | $0.1957 |
| Median price | $0.3091 |
| Average price | $0.5629 |
| Largest weekly change | +72.4% (Nov 20, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Indomethacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of INDOMETHACIN ER 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for INDOMETHACIN ER 75 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.2099 per EA (NDC 31722056560), effective Sep 30, 2026.
How has the price of INDOMETHACIN ER 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for INDOMETHACIN ER 75 MG CAPSULE has declined 84.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INDOMETHACIN ER 75 MG CAPSULE?
Since Nov 28, 2013, the NADAC for INDOMETHACIN ER 75 MG CAPSULE has ranged from a low of $0.1511 (Nov 20, 2024) to a high of $1.4920 (Feb 12, 2014), with a median of $0.3091 per EA.
Are there cheaper alternatives to INDOMETHACIN ER 75 MG CAPSULE?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INDOMETHACIN ER 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures INDOMETHACIN ER 75 MG CAPSULE?
INDOMETHACIN ER 75 MG CAPSULE (NDC 31722056560) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.